More on RCUS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+30.7% Growth)
- Ratings (8.3 Score)
- Holders

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Arcus Biosciences (NY:RCUS)
Delayed: 22.12 -0.7 (3.07%)
Prev. Close $22.82  
Open$22.79 
52 Wk High$ 
52 Wk Low$ 
Day High$22.96 
Day Low$21.60 
P/E N/A  
EPS$ 
Volume1,425,533 

Friends, Peers and Foes (?): 0A3M, BMS, BMY, 4RY SMMT (more...)

Oct 16, 2026 03:14 AM William Blair Starts Arcus Biosciences (RCUS) at Outperform
Oct 14, 2026 02:51 AM JPMorgan Starts Arcus Biosciences (RCUS) at Overweight
Oct 9, 2026 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Sep 28, 2026 02:21 PM Form CT ORDER Arcus Biosciences, Inc.
Sep 24, 2026 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Sep 22, 2026 08:30 AM Arcus Biosciences to Host Investor Event Featuring New Data for Casdatifan as a Treatment for Kidney Cancer Across Multiple Lines of Therapy
Sep 22, 2026 08:13 AM Arcus Biosciences (RCUS) Reiterated at Overweight by Cantor Fitzgerald
Sep 16, 2026 05:30 AM TD Cowen Starts Arcus Biosciences (RCUS) at Buy
Sep 11, 2026 07:03 AM Arcus Biosciences (RCUS) Reiterated at Overweight by Cantor Fitzgerald After CFO Chat
Sep 9, 2026 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
View All Articles

Entities mentioned with RCUS

View All Entities